Yali Zhang

机构：Roswell Park Comprehensive Cancer Center, Harbin Institute of Technology, Wenzhou Medical University, Huazhong University of Science and Technology · ORCID：0000-0002-0694-696X

发表论文 66 篇 · 总被引 2413 次 · h-index 30

代表论文

• Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation (2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 73)
• Research methods for animal models of atherosclerosis (Review) (2021 · Molecular Medicine Reports · 被引 44)
• Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells (2020 · Frontiers in Cell and Developmental Biology · 被引 38)
• Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice (2021 · Acta Pharmacologica Sinica · 被引 34)
• Configuration Design and Interface Reconstruction to Realize the Superior High‐Rate Performance for Sodium Layered Oxide Cathodes (2025 · Advanced Energy Materials · 被引 30)
• Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2 (2021 · Acta Pharmacologica Sinica · 被引 30)